Gore Tex Implants in the Treatment of Atrophic Rhinitis (RA)

This study has suspended participant recruitment.
(lack of new patients)
Sponsor:
Information provided by:
Hospital Felicio Rocho
ClinicalTrials.gov Identifier:
NCT00832403
First received: January 27, 2009
Last updated: January 29, 2009
Last verified: January 2009

January 27, 2009
January 29, 2009
November 2006
February 2008   (final data collection date for primary outcome measure)
improvement of fetid crusts and atrophy of the mucous bone covering [ Time Frame: after surgery recovery ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00832403 on ClinicalTrials.gov Archive Site
lack of side effects such as infection [ Time Frame: after the treatment ] [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
 
Gore Tex Implants in the Treatment of Atrophic Rhinitis
Gore Tex Implants in the Treatment of Atrophic Rhinitis

This is a retrospective study, involving patients with atrophic rhinitis, that underwent Gore tex® implants in the nasal fossa.

The Fetid Rhinitis or Atrophic Ozena is a chronic illness characterized by yellowish secretion in the initial phase and the other phases with fetid crusts and atrophy of the mucous bone covering. Diverse theories exist that try to explain the appearance of this pathology, such as: hereditary factors, immunological alterations, viral infection and nutritional lack. Currently, its etiology remains unknown. As there isn't any ideal treatment already established, this technique improves the options of treatment.

All patients have improved after the procedure.

Data about 5 patients that underwent surgery to implant polytetrafluoroethylene in the nasal fossa was collect. The symptoms and complications were described.

Observational
Observational Model: Case-Only
Time Perspective: Retrospective
Not Provided
Not Provided
Non-Probability Sample

Patients that were submit to surgery to treat atrophic rhinitis with implants in the nasal fossa.

Atrophic Rhinitis
Other: implants of polytetrafluoroethylene in tha nasal fossa
surgical implants of polytetrafluoroethylene in the nasal fossa
polytetrafluoroethylene
Intervention: Other: implants of polytetrafluoroethylene in tha nasal fossa
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Suspended
5
Not Provided
February 2008   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Symptoms of atrophic rhinitis, with previous clinical treatment without good results

Exclusion Criteria:

  • Patients with mental illness
Both
Not Provided
No
Contact information is only displayed when the study is recruiting subjects
Not Provided
 
NCT00832403
Rinite Atrófica cep/hfr
No
Larissa Oliveira Lauriano, Hospital Felício Rocho
Hospital Felicio Rocho
Not Provided
Not Provided
Hospital Felicio Rocho
January 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP